Literature DB >> 18193340

Disorders of apoptosis: mechanisms for autoimmunity in primary immunodeficiency diseases.

João Bosco Oliveira1, Sudhir Gupta.   

Abstract

A number of primary immunodeficiency diseases represent a paradox of immunodeficiency and autoimmunity. In this minireview, we present basic concepts of apoptosis and disorder of apoptosis as one of the mechanisms to explain such a paradox between immunodeficiency and autoimmunity, which is exemplified by autoimmune lymphoproliferative syndrome (ALPS).

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18193340     DOI： 10.1007/s10875-007-9161-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN： 0271-9142            Impact factor:   8.542


  42 in total

Review 1.  Molecular steps of death receptor and mitochondrial pathways of apoptosis.

Authors:  S Gupta
Journal:  Life Sci       Date:  2001-11-09       Impact factor: 5.037

2.  TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.

Authors:  J J Bleesing; M R Brown; J K Dale; S E Straus; M J Lenardo; J M Puck; T P Atkinson; T A Fleisher
Journal:  Clin Immunol       Date:  2001-09       Impact factor: 3.969

3.  Two CD95 (APO-1/Fas) signaling pathways.

Authors:  C Scaffidi; S Fulda; A Srinivasan; C Friesen; F Li; K J Tomaselli; K M Debatin; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

4.  Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.

Authors:  J J Bleesing; M R Brown; S E Straus; J K Dale; R M Siegel; M Johnson; M J Lenardo; J M Puck; T A Fleisher
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

5.  A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

Authors:  M C Sneller; S E Straus; E S Jaffe; J S Jaffe; T A Fleisher; M Stetler-Stevenson; W Strober
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Autoimmune lymphoproliferative syndrome with somatic Fas mutations.

Authors:  Eliska Holzelova; Cédric Vonarbourg; Marie-Claude Stolzenberg; Peter D Arkwright; Françoise Selz; Anne-Marie Prieur; Stéphane Blanche; Jirina Bartunkova; Etienne Vilmer; Alain Fischer; Françoise Le Deist; Frédéric Rieux-Laucat
Journal:  N Engl J Med       Date:  2004-09-30       Impact factor: 91.245

7.  Dendritic cell apoptosis in the maintenance of immune tolerance.

Authors:  Min Chen; Yui-Hsi Wang; Yihong Wang; Li Huang; Hector Sandoval; Yong-Jun Liu; Jin Wang
Journal:  Science       Date:  2006-02-24       Impact factor: 47.728

8.  Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.

Authors:  Hyung J Chun; Lixin Zheng; Manzoor Ahmad; Jin Wang; Christina K Speirs; Richard M Siegel; Janet K Dale; Jennifer Puck; Joie Davis; Craig G Hall; Suzanne Skoda-Smith; T Prescott Atkinson; Stephen E Straus; Michael J Lenardo
Journal:  Nature       Date:  2002-09-26       Impact factor: 49.962

Review 9.  Genetic disorders of programmed cell death in the immune system.

Authors:  Nicolas Bidère; Helen C Su; Michael J Lenardo
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

10.  Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

Authors:  Lilia L Bi; George Pan; T Prescott Atkinson; Lixin Zheng; Janet K Dale; Christopher Makris; Vishnu Reddy; Jay M McDonald; Richard M Siegel; Jennifer M Puck; Michael J Lenardo; Stephen E Straus
Journal:  BMC Med Genet       Date:  2007-07-02       Impact factor: 2.103
View more
  12 in total

Review 1.  Immunostimulation in the era of the metagenome.

Authors:  Amy D Proal; Paul J Albert; Greg P Blaney; Inge A Lindseth; Chris Benediktsson; Trevor G Marshall
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

2.  Apoptosis - is it good or bad.

Authors:  Bakir Mehić
Journal:  Bosn J Basic Med Sci       Date:  2012-08       Impact factor: 3.363

3.  The effect of intra-articular injection of different concentrations of ozone on the level of TNF-α, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis.

Authors:  Huiqiang Chen; Bin Yu; Changhuai Lu; Qingrong Lin
Journal:  Rheumatol Int       Date:  2012-10-02       Impact factor: 2.631

Review 4.  Tolerance and autoimmunity in primary immunodeficiency disease: a comprehensive review.

Authors:  Sudhir Gupta; Ankmalika Gupta Louis
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 5.  Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases.

Authors:  Liutao Du; Richard A Gatti
Journal:  J Immunol Methods       Date:  2010-12-13       Impact factor: 2.303

Review 6.  Cell death.

Authors:  Richard S Hotchkiss; Andreas Strasser; Jonathan E McDunn; Paul E Swanson
Journal:  N Engl J Med       Date:  2009-10-15       Impact factor: 91.245

7.  The Fas-FADD death domain complex structure reveals the basis of DISC assembly and disease mutations.

Authors:  Liwei Wang; Jin Kuk Yang; Venkataraman Kabaleeswaran; Amanda J Rice; Anthony C Cruz; Ah Young Park; Qian Yin; Ermelinda Damko; Se Bok Jang; Stefan Raunser; Carol V Robinson; Richard M Siegel; Thomas Walz; Hao Wu
Journal:  Nat Struct Mol Biol       Date:  2010-10-10       Impact factor: 15.369

Review 8.  Structural features of caspase-activating complexes.

Authors:  Hyun Ho Park
Journal:  Int J Mol Sci       Date:  2012-04-16       Impact factor: 6.208

9.  Midazolam regulated caspase pathway, endoplasmic reticulum stress, autophagy, and cell cycle to induce apoptosis in MA-10 mouse Leydig tumor cells.

Authors:  Edmund Cheung So; Yung-Chia Chen; Shu-Chun Wang; Chia-Ching Wu; Man-Chi Huang; Meng-Shao Lai; Bo-Syong Pan; Fu-Chi Kang; Bu-Miin Huang
Journal:  Onco Targets Ther       Date:  2016-04-27       Impact factor: 4.147

Review 10.  The characteristics of Bax inhibitor-1 and its related diseases.

Authors:  B Li; R K Yadav; G S Jeong; H-R Kim; H-J Chae
Journal:  Curr Mol Med       Date:  2014       Impact factor: 2.222
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.